Clinical trial
Drug Utilization Study for Pirinase Hayfever Relief for Adults 0.05% Nasal Spray
NCT02856282 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Drug Utilization Study for Pirinase Hayfever Relief for Adults 0.05% Nasal Spray
- Lead sponsor
- GlaxoSmithKline
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 15, 2016
- Completion date
- March 31, 2018
- Enrollment
- 46 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.